• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Tuesday, June 24, 2025
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

Cells optimised to produce substance that holds potential to improve ‘healthy ageing’

Bioengineer by Bioengineer
June 18, 2021
in Health
Reading Time: 3 mins read
0
ADVERTISEMENT
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

IMAGE

Credit: The Novo Nordisk Foundation Center for Biosustainability

The population on Earth is increasingly growing and people are expected to live longer in the future. Thus, better and more reliable therapies to treat human diseases such as Alzheimer’s and cardiovascular diseases are crucial. To cope with the challenge of ensuring healthy ageing, a group of international scientists investigated the potential of biosynthesising several polyamines and polyamines analogues with already known functionalities in treating and preventing age-related diseases.

One of the most interesting molecules to study was spermidine, which is a natural product already present in people’s blood and an inducer of autophagy that is an essential cellular process for clearing damaged proteins, e.g., misfolded proteins in brain cells that can cause Alzheimer’s. When people get older the level of spermidine in the blood decrease and dietary supplements, or certain food products are needed to maintain a stable and high level of spermidine in the blood. However, those products are difficult to produce with traditional chemistry due to their structural complexity and extraction of natural resources is neither a commercially viable nor a sustainable approach.

Therefore, the researchers instead decided to open their biochemical toolbox and use classical metabolic engineering strategies to engineer the yeast metabolism to produce polyamines and polyamines analogues.

“This group of molecules has huge potential in addressing important societal challenges and it seemed logical to try and produce them with the help of biology,” emphasises Jiufu Qin, Senior Researcher at The Novo Nordisk Foundation Center for Biosustainability, DTU.

Solid vantage point

The team of scientists explored seven biosynthetic routes that synthesises spermidine from arginine or ornithine and by employing flux balance analysis they could estimate the maximum theoretical yield of each pathway.

After establishing the most efficient pathway for spermidine and systematically engineering the cellular metabolism of yeast they managed to ultimately reach a production of spermidine at titers 2.3 gram per liter on lab scale. An initial result that proves the potential of utilising nature’s large and diverse reservoir of biochemical tools to push forward products that can meet the challenges of population ageing and a lack of sufficient food supplies.

“We expect that our studies lay the groundwork for fermentation-based manufacture of diverse polyamines and polyamine analogues to further unlock this field’s potential for pharmacological and agricultural applications, “says Jens Nielsen, Professor at Chalmers University of Technology and CEO at BioInnovation Institute.

But all that glitter is not gold and an obstacle such as low enzyme activity causing feedback regulation and thereby compromising the product yield still needs to be overcome.

Hit the nail on the head

Even though the strain might need to be improved further, scale-up towards commercial production is already ongoing since the current titers are deemed sufficient for initialising production.

The company Chrysea Labs has been established based on this scientific study and the company has a mission of developing healthy lifespan nutritional interventions by ameliorating the natural occurring anti-ageing mechanism autophagy that recycle the cellular process, which is critical for maintaining cell health, renewal and survival.

Since the market is expected to grow in the coming years and only a few competitors are currently present in the field there might be a window of opportunity for Chrysea Labs to be a frontrunner in ensuring healthy ageing.

###

Media Contact
Anders Moensted
[email protected]

Related Journal Article

http://dx.doi.org/10.1038/s41929-021-00631-z

Tags: AlzheimerBiochemistryBiologyBiomedical/Environmental/Chemical EngineeringBiotechnologyCell BiologyClinical TrialsMolecular Biologyneurobiology
Share13Tweet8Share2ShareShareShare2

Related Posts

Metabolic Messengers: The Role of Oestradiol

Metabolic Messengers: The Role of Oestradiol

June 24, 2025
blank

HSV1 Glycoprotein D Blocks Alpha7 Nicotinic Receptors

June 24, 2025

Deep Learning Predicts Walking Forces with Knee Alignment

June 24, 2025

Robotic Intubation and AI Airway Tech

June 24, 2025
Please login to join discussion

POPULAR NEWS

  • Green brake lights in the front could reduce accidents

    Study from TU Graz Reveals Front Brake Lights Could Drastically Diminish Road Accident Rates

    161 shares
    Share 64 Tweet 40
  • Pancreatic Cancer Vaccines Eradicate Disease in Preclinical Studies

    72 shares
    Share 29 Tweet 18
  • Enhancing Broiler Growth: Mannanase Boosts Performance with Reduced Soy and Energy

    66 shares
    Share 26 Tweet 17
  • How Scientists Unraveled the Mystery Behind the Gigantic Size of Extinct Ground Sloths—and What Led to Their Demise

    65 shares
    Share 26 Tweet 16

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Cell Therapy Enhances Survival Rates in Colorectal Cancer Patients

Metabolic Messengers: The Role of Oestradiol

Pulmonary T2* MRI: New Fetal Lung Assessment Tool?

  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.